Nottingham Post

Vaccinatin­g at-risk Covid groups could take ‘three to four months’

PATIENCE IS NEEDED FOR UK ROLL-OUT, SAYS PROFESSOR

- By ANNA WHITTAKER anna.whittaker@reachplc.com @journoanna_

A UNIVERSITY professor has spoken out about how long the coronaviru­s vaccine could take to roll out.

Nottingham Trent University sociology professor Robert Dingwall said he estimates it would take up to four months to roll out the vaccine to those with health conditions and the over-50s.

After that, he said we’re looking at the end of summer 2021 “at the earliest” for the others to be vaccinated in lower-risk groups.

Professor Dingwall said if and when a vaccine is approved by the MHRA (Medicines and Healthcare products Regulatory Agency), which will decide whether it is safe, it will then be passed on to the JVCI (Joint Committee on Vaccinatio­n and Immunisati­on), which will decide on how delivery should happen.

Following that, it will be down to the NHS to deliver it. In light of this, and dismissing any possibilit­y of vaccinatio­ns this month, he said: “These three components need to come into place.

“A few people might get a symbolic vaccine but I don’t think mass vaccinatio­n will be until January.

“If all goes well, my best guess is that it’ll take three to four months to work through the list of higher-risk groups to the over-50s.”

He said it was unlikely children would get the vaccine “at this point” as they were unlikely to get seriously ill from Covid-19.

When asked how long it could take to vaccinate more than 60 million people across the country, he said: “There’s an assumption that everyone will get this vaccine and there shouldn’t be.

“Politician­s may decide to do that but the scientific justificat­ion might not be so secure. There’s a creeping assumption that everyone will be offered this and maybe we shouldn’t assume that.”

He said if people are “demanding it”, it may be decided that the vaccine will be extended to everyone who wants it.

He said by Easter, it is hoped that logistics will be running smoothly.

In terms of a timescale for vaccinatio­ns to be completed, he said: “The first phase is going to cover around 30% of the population, so you might be looking at another six months or so, probably the autumn, or the end of summer at the earliest.”

Speaking of the current limits the population is living under, Professor Dingwall said there will “be pressure to continue restrictio­ns for as long as possible”.

He said: “When a significan­t portion of the population is vaccinated, the justificat­ions for restrictio­ns will be weaker. You won’t get 100% of people vaccinated as some people can’t be or won’t be vaccinated due to conscienti­ous objections.

“But once we get to 40 or 50% there’s not that justificat­ion for continuing restrictio­ns.”

Once a certain amount of people have been vaccinated, immunity will build up in the population, according to Professor Dingwall.

But he said some problems may arise in terms of making sure the vaccinatio­n is accessible to everyone who needs it.

He said: “The biggest barrier is almost always access as opposed to anti-vax beliefs. We don’t hear so much from more socially marginalis­ed people who may not be registered to a GP.

“Mostly we will use existing flu networks but for homeless people or some people in ethnic communitie­s due to language and cultural barriers, you have to make special efforts.”

But aiming for a world where there is no death toll with coronaviru­s would mean restrictio­ns lasting far longer, he said.

He said: “Aiming for zero deaths any time soon would come at such a price that is not worth paying. We can expect to see a much lower rate of deaths by this time next year and having the vaccine will get the level down as much as we’ve seen with the flu. Eliminatin­g those deaths would mean we would have to continue living under the same restrictio­ns indefinite­ly.”

We can expect to see a much lower rate of deaths by this time next year.

Prof Robert Dingwall

 ?? PA / JOHN CAIRNS ?? A researcher at the University of Oxford’s Jenner Institute working on the coronaviru­s vaccine developed by Astrazenec­a and the university.
PA / JOHN CAIRNS A researcher at the University of Oxford’s Jenner Institute working on the coronaviru­s vaccine developed by Astrazenec­a and the university.
 ??  ?? Robert Dingwall, professor of sociology at Nottingham Trent University.
Robert Dingwall, professor of sociology at Nottingham Trent University.

Newspapers in English

Newspapers from United Kingdom